Biosimilar Medicines

“Biosimilar Medicines”
A Non-branded, Educational Program

Presenter:
James Surapisitchat, Ph.D.
Medical Science Liaison, Oncology, Teva Pharmaceuticals

Presentation outline:

• Review the current use of biologics
• Understand key differences between biologics and small molecule pharmaceuticals
• Understand key definitions in biosimilar drug development
• Discuss the U.S. FDA biosimilar approval process
• Apply understanding of approval process in a case study